Ameritas Investment Partners’s Viking Therapeutics VKTX Stock Holding History

Ameritas Investment Partners’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,278	Closed	-$843K	–	3237
2024 Q1	$843K	Buy	10,278 +725	+8%	+$32.3K	0.03%	665
2023 Q4	$178K	Hold	9,553	–	–	0.01%	1342
2023 Q3	$106K	Buy	9,553 +1,613	+20%	+$23.1K	﹤0.01%	1611
2023 Q2	$129K	Buy	+7,940	New	+$166K	﹤0.01%	1420
2022 Q2	–	Sell	-5,553	Closed	-$17K	–	3243
2022 Q1	$17K	Hold	5,553	–	–	﹤0.01%	2631
2021 Q4	$26K	Hold	5,553	–	–	﹤0.01%	2522
2021 Q3	$35K	Hold	5,553	–	–	﹤0.01%	2381
2021 Q2	$33K	Hold	5,553	–	–	﹤0.01%	2456
2021 Q1	$35K	Hold	5,553	–	–	﹤0.01%	2291
2020 Q4	$31K	Hold	5,553	–	–	﹤0.01%	2263
2020 Q3	$32K	Hold	5,553	–	–	﹤0.01%	2125
2020 Q2	$40K	Hold	5,553	–	–	﹤0.01%	1968
2020 Q1	$26K	Hold	5,553	–	–	﹤0.01%	2034
2019 Q4	$45K	Hold	5,553	–	–	﹤0.01%	1988
2019 Q3	$38K	Hold	5,553	–	–	﹤0.01%	2039
2019 Q2	$46K	Buy	5,553 +1,282	+30%	+$11K	﹤0.01%	1969
2019 Q1	$42K	Hold	4,271	–	–	﹤0.01%	1989
2018 Q4	$33K	Hold	4,271	–	–	﹤0.01%	2050
2018 Q3	$74K	Sell	4,271 -93	-2%	-$1.11K	﹤0.01%	1747
2018 Q2	$41K	Buy	+4,364	New	+$29K	﹤0.01%	2115

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameritas Investment Partners's VKTX Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 10,278 shares — an estimated $843K sold.

Ameritas Investment Partners first reported a position in VKTX in Q2 2018 and held it in 20 quarters. The position peaked at $843K in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

Ameritas Investment Partners reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 10,278 Viking Therapeutics shares in Q2 2024, an estimated $843K.
Ameritas Investment Partners first reported a position in Viking Therapeutics in Q2 2018 and held it in 20 quarters.
Ameritas Investment Partners's Viking Therapeutics position peaked at $843K in Q1 2024.
387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.